COGNANO Inc. (hereinafter "the Company") is pleased to announce the release and provision of our high-quality VHH samples for academic research evaluation, aimed at further advancing the field of oncology.
Leveraging cutting-edge bioinformatics technology, we have enabled approaches to targets that were previously difficult to reach with conventional antibodies. We invite you to integrate our high-precision samples into your research workflow and evaluate their utility. Through this data evaluation, we are actively seeking research institutions and corporations to explore opportunities for future joint development and strategic partnerships.
Overview of VHH Samples Provision
This program is designed for R&D partners aiming to establish next-generation drug discovery and diagnostic technologies.
- Early Distribution Prior to Official Announcement: We are offering exclusive, limited access to our data ahead of the official presentation at AACR 2026 (American Association for Cancer Research) in San Diego this April.
- Ready for Immediate Validation: The samples are structured for immediate validation in analyses involving cryo-tissues and cells.
- A First Step Toward Joint Development: Based on the results of the data evaluation, we aim to establish strategic alliances, including joint R&D and licensing agreements.
- Complimentary Access for R&D Partners: To support promising scientific outcomes, we provide the samples as complimentary "Pilot Access" to selected research partners.
Application Procedures
To request access to our VHH samples, please follow the steps below:
- Application via Dedicated Form: Please enter the required information and a summary of your research through the "VHH Dataset Sample Request for Research Evaluation."collaboration-sample-data-requestCOGNANO provides high-quality VHH datasets for academic research evaluation. Please fill out the form below to request access. Please note that access to the dataset is subject to your agreement to the "Material Transfer Agreement (MTA) for VHH Antibodies”.
https://cognanous.com/collaboration-sample-data-request
- Agreement and Data Provision: Access is subject to your agreement to the "Material Transfer Agreement (MTA) for VHH Antibodies" as detailed below.
To receive the data, you are required to agree to the Company’s standard "Material Transfer Agreement (MTA) for VHH Antibodies" For further details, please refer to the application form.
The Company will be participating in AACR 2026 in San Diego in April 2026. We look forward to engaging in technical discussions based on your data evaluation and exploring detailed partnership schemes on-site. If you wish to schedule a private meeting, please contact us in advance.